GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,774.50p
   
  • Change Today:
    -3.50p
  • 52 Week High: 1,812.50p
  • 52 Week Low: 1,316.00p
  • Currency: UK Pounds
  • Shares Issued: 4,144.92m
  • Volume: 4,163,120
  • Market Cap: £73,552m
  • RiskGrade: 129

Broker Views

Show broker recommendations:
Show broker actions:
Date Broker name New Price Old price target New price target Broker change
07-May-24 Barclays Equal-weight 1,761.00p - 1,725.00p Reiteration
02-May-24 JP Morgan Cazenove Underweight 1,728.50p 1,530.00p 1,660.00p Reiteration
01-May-24 Shore Capital Buy 1,705.00p - - Reiteration
17-Apr-24 Deutsche Buy 1,590.00p - 1,950.00p Reiteration
08-Apr-24 Barclays Equal-weight 1,620.00p - 1,725.00p Reiteration
12-Mar-24 Deutsche Buy 1,685.20p - 1,950.00p Reiteration
07-Mar-24 Shore Capital Buy 1,711.20p - - Reiteration
27-Feb-24 Deutsche Buy 1,671.00p - 1,950.00p Reiteration
15-Feb-24 Shore Capital Buy 1,663.00p - - Reiteration
14-Feb-24 Berenberg Bank Buy 1,668.00p 1,650.00p 1,820.00p Reiteration
09-Feb-24 Barclays Buy 1,660.00p - 1,950.00p Reiteration
31-Jan-24 Shore Capital Buy 1,568.00p - - Reiteration
18-Dec-23 Barclays Equal-weight 1,442.60p - 1,575.00p Reiteration
28-Nov-23 Citigroup Neutral 1,411.80p - - Reiteration
24-Nov-23 Berenberg Bank Buy 1,422.60p - 1,650.00p Reiteration
06-Nov-23 Barclays Equal-weight 1,405.00p - 1,575.00p Reiteration
11-Oct-23 Shore Capital Buy 1,519.20p - - Reiteration
03-Oct-23 Deutsche Buy 1,485.20p - - Reiteration
02-Oct-23 Citigroup Neutral 1,484.00p - - Reiteration
29-Sep-23 JP Morgan Cazenove Underweight 1,492.00p - - Reiteration
08-Sep-23 JP Morgan Cazenove Underweight 1,444.20p - - Reiteration
05-Sep-23 Deutsche Buy 1,381.40p - 1,700.00p Reiteration
04-Sep-23 Barclays Equal-weight 1,373.60p - 1,450.00p Reiteration
28-Jul-23 Berenberg Bank Buy 1,383.00p - 1,730.00p Reiteration
20-Jul-23 JP Morgan Cazenove Underweight 1,387.20p - - Reiteration
26-Jun-23 Citigroup Neutral 1,419.80p - 1,700.00p Reiteration
26-Jun-23 Jefferies Hold 1,419.80p - 1,575.00p Reiteration
16-Jun-23 Shore Capital Buy 1,364.60p - - Reiteration
14-Jun-23 JP Morgan Cazenove Underweight 1,363.40p - 1,400.00p Reiteration
05-Jun-23 Berenberg Bank Buy 1,382.00p - 1,730.00p Reiteration
30-May-23 Citigroup Neutral 1,371.00p - - Reiteration
30-May-23 Deutsche Buy 1,371.00p - 1,700.00p Reiteration
16-May-23 Deutsche Buy 1,466.00p - 1,700.00p Reiteration
15-May-23 Shore Capital Buy 1,469.60p - - Reiteration
09-May-23 JP Morgan Cazenove Underweight 1,446.20p - - Reiteration
04-May-23 Shore Capital Buy 1,466.20p - - Reiteration
27-Apr-23 JP Morgan Cazenove Underweight 1,437.00p - 1,400.00p Reiteration
27-Apr-23 Barclays Equal-weight 1,437.00p - 1,450.00p Reiteration
27-Apr-23 Deutsche Buy 1,437.00p - 1,700.00p Reiteration
26-Apr-23 Shore Capital Buy 1,442.20p - - Reiteration
19-Apr-23 Berenberg Bank Buy 1,485.80p - 1,730.00p Reiteration
12-Apr-23 Shore Capital Buy 1,512.60p - - Reiteration
11-Apr-23 Barclays Equal-weight 1,506.40p - 1,450.00p Reiteration
04-Apr-23 Deutsche Buy 1,449.00p - 1,700.00p Reiteration
28-Mar-23 JP Morgan Cazenove Underweight 1,421.00p - - Reiteration
24-Mar-23 Shore Capital Buy 1,401.20p - - Reiteration
17-Mar-23 Deutsche Buy 1,400.80p 15,000.00p 17,000.00p Upgrade
08-Mar-23 Deutsche Hold 1,422.40p - 1,500.00p Reiteration
28-Feb-23 Deutsche Hold 1,425.40p - 1,500.00p Reiteration
24-Feb-23 Shore Capital Buy 1,445.00p - - Reiteration

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Consensus broker estimates sourced from FactSet Research Systems Inc., who calculate consensus using only those estimates changed or actively validated within the last 75 days.

 

GSK Market Data

Currency UK Pounds
Share Price 1,774.50p
Change Today -3.50p
% Change -0.20 %
52 Week High 1,812.50p
52 Week Low 1,316.00p
Volume 4,163,120
Shares Issued 4,144.92m
Market Cap £73,552m
RiskGrade 129

GSK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
60.77% below the market average60.77% below the market average60.77% below the market average60.77% below the market average60.77% below the market average
21.57% above the sector average21.57% above the sector average21.57% above the sector average21.57% above the sector average21.57% above the sector average
Price Trend
46.27% above the market average46.27% above the market average46.27% above the market average46.27% above the market average46.27% above the market average
55.56% above the sector average55.56% above the sector average55.56% above the sector average55.56% above the sector average55.56% above the sector average
Income
8.93% above the market average8.93% above the market average8.93% above the market average8.93% above the market average8.93% above the market average
Sector averageSector averageSector averageSector averageSector average
Growth
19.94% below the market average19.94% below the market average19.94% below the market average19.94% below the market average19.94% below the market average
29.41% above the sector average29.41% above the sector average29.41% above the sector average29.41% above the sector average29.41% above the sector average

What The Brokers Say

Strong Buy 8
Buy 5
Neutral 9
Sell 2
Strong Sell 0
Total 24
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GSK Dividends

  Latest Previous
  Q1 Q4
Ex-Div 16-May-24 22-Feb-24
Paid 11-Jul-24 11-Apr-24
Amount 15.00p 16.00p

Trades for 24-May-2024

Time Volume / Share Price
16:50 485 @ 1,774.50p
16:35 1,703,689 @ 1,774.50p
16:35 9,584 @ 1,774.50p
16:35 1,516 @ 1,774.50p
16:35 1,138 @ 1,774.50p

GSK Key Personnel

CEO Emma Walmsley

Top of Page